Rabin Medical Center
Petah Tikva, Israel
NCT Number: NCT07022314
This prospective observational study evaluates the real-time urine output response to fluid therapy and diuretics in cardiothoracic intensive care unit (CTICU) patients monitored with the FIZE kUO® device. The study aims to assess how continuous urine output monitoring can inform fluid management and improve patient outcomes post-cardiac surgery.
Trial opening soon.
Get Notified18 year and older
All sexes
Observational
Petah Tikva, Israel
The study involves adult patients undergoing coronary artery bypass graft (CABG) or valve replacement/repair surgeries. Utilizing the FIZE kUO® device, continuous urine output data will be collected to analyze responses to hemodynamic interventions, including fluid boluses and diuretics. Secondary objectives include assessing urine output differences in patients with and without postoperative acute kidney injury (AKI), responses to vasopressors, and capturing real-time urine output data from FIZE kUO® for observational analysis.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
FIZE kUO® is a commercially available, non-invasive device used for continuous, minute-by-minute real-time urine output monitoring in patients with an indwelling Foley catheter. In this observational study, the device is used during and after cardiac surgery as part of routine clinical care. Urine output data, along with additional clinical parameters, are collected throughout the study for research analysis.
Time frame: 4 hours (2 hours before and 2 hours after intervention)
Change in urine output measured by FIZE kUO® during 2 hours before and after fluid or diuretic administration.
Time frame: Perioperative/Periprocedural
Comparison of urine output measured by FIZE kUO® in patients who develop AKI vs. those who do not
Time frame: 4 hours (2 hours before and 2 hours after intervention)
Change in urine output measured by FIZE kUO® before and after vasopressor administration
Time frame: Through ICU stay, up to 5 days
Comparison of FIZE kUO® urine output with manual measurement of urine output
Contact information is provided by the study sponsor or research team.
FIZE Medical ltd
Industry
FIZE kUO® Real-Time Measurement of Urine Output Response to Fluid Therapy and Diuretics in Cardiovascular Surgery Patients: A Prospective Post-Market Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07722325
AKI - Acute Kidney Injury, Acute Kidney Injury
View Trial DetailsNCT07661940
AKI - Acute Kidney Injury, Acute Kidney Injury
Erlangen, Bavaria, Germany
View Trial DetailsNCT06564376
AKI - Acute Kidney Injury, Acute Kidney Injury
Morgantown, West Virginia, United States
View Trial DetailsNCT07617675
AKI - Acute Kidney Injury, Acute Kidney Injury
Beijing, China
View Trial Details